financetom
Business
financetom
/
Business
/
Trimble beats Q3 revenue expectations, raises guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trimble beats Q3 revenue expectations, raises guidance
Nov 5, 2025 4:38 AM

Overview

* Trimble Q3 revenue of $901.2 mln beats analyst expectations, up 3% yr/yr

* Adjusted EPS for Q3 at $0.81 beats consensus estimates

* Company raises full-year 2025 guidance, reflecting strong execution of strategy

Outlook

* Trimble raises full-year 2025 revenue guidance to $3,545 mln-$3,585 mln

* Company expects Q4 2025 revenue between $927 mln and $967 mln

* Trimble forecasts full-year 2025 non-GAAP EPS of $3.04 to $3.12

Result Drivers

* RECURRING REVENUE - Record annualized recurring revenue of $2.31 bln, driven by Connect & Scale strategy

* GROSS MARGIN - Record gross margin achieved in Q3

* SHARE REPURCHASE - $50 mln in share repurchases during Q3, contributing to EPS performance

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $901.20 $870.32

Revenue mln mln (9

Analysts

)

Q3 Beat $0.81 $0.71

Adjusted (10

EPS Analysts

)

Q3 Beat $194.70 $171.66

Adjusted mln mln (8

Net Analysts

Income )

Q3 Net $111.50

Income mln

Q3 Beat $269.40 $242.72

Adjusted mln mln (6

EBITDA Analysts

)

Q3 $150.50

operatin mln

g income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy"

* Wall Street's median 12-month price target for Trimble Inc ( TRMB ) is $95.00, about 17.3% above its November 4 closing price of $78.60

* The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 27 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LZ Technology Says Principal Shareholders Extend Lock-Up to August 2026
LZ Technology Says Principal Shareholders Extend Lock-Up to August 2026
Aug 13, 2025
09:03 AM EDT, 08/13/2025 (MT Newswires) -- LZ Technology ( LZMH ) said Wednesday all of its principal shareholders have agreed to extend their lock-up restrictions until Aug. 31, 2026, from the original 180-day period following the company's February initial public offering. The extension covers holders of about 100% of the company's Class A shares and 96.19% of Class B...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
ImmunityBio Says CD19 CAR-NK Early Phase Trial Shows Complete Responses in Non-Hodgkin Lymphoma Patients
ImmunityBio Says CD19 CAR-NK Early Phase Trial Shows Complete Responses in Non-Hodgkin Lymphoma Patients
Aug 13, 2025
09:16 AM EDT, 08/13/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Wednesday that early findings from a phase I trial using its CD19 CAR-NK natural killer cell therapy showed complete responses in the first patients treated so far with late-stage Waldenstrom macroglobulinemia, a type of non-Hodgkins lymphoma. The study is a first-in-human trial assessing the safety and preliminary efficacy...
Oil Trading at 10-Week Low as IEA Cuts Demand Forecast and Raises  Supply Outlook
Oil Trading at 10-Week Low as IEA Cuts Demand Forecast and Raises Supply Outlook
Aug 13, 2025
09:18 AM EDT, 08/13/2025 (MT Newswires) -- Oil prices fell to a ten-week low early on Wednesday as another major forecasting agency warned global inventories are on the rise amid higher supply while a report showed an unexpected hike in U.S. inventories. West Texas Intermediate crude was last seen down US$0.19 to US$62.98, the lowest since June 2, while October...
Copyright 2023-2026 - www.financetom.com All Rights Reserved